Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-१.७९%
१,०४७.१४
-१९.०४
-१.७९%
—१,०६६.२११,०६४.९४१,०६४.९४१,०३८.७७——
SIXC
Communications
SIXC
Communications
SIXC
-०.७८%
६०६.३७
-४.७९
-०.७८%
—६११.१६६११.१६६१२.२५६०५.१८——
SIXE
Energy
SIXE
Energy
SIXE
+०.७८%
१,२७९.८१
+९.८८
+०.७८%
—१,२६९.९३१,२७३.१६१,२८०.९२१,२६२.६९——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.५१%
१,७११.६६
-८.७५
-०.५१%
—१,७२०.४११,७१७.३९१,७१७.३९१,६९४.४७——
SIXM
Financials
SIXM
Financials
SIXM
-०.४५%
६३४.२९
-२.८४
-०.४५%
—६३७.१३६३७.४०६३७.७४६३१.७७——
SIXR
Staples
SIXR
Staples
SIXR
+०.१९%
८६७.९१
+१.६६
+०.१९%
—८६६.२५८६५.७७८७४.१२८५८.७२——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+०.४२%
२१५.५५
+०.८८
+०.४२%
—२१४.६४२१४.६४२१६.०८२१३.४९——
SIXT
Technology
SIXT
Technology
SIXT
-०.००%
३,५११.०७
-०.०६०
-०.००%
—३,५११.१३३,४८१.०७३,५२७.५९३,४४०.२०——
SIXU
Utilities
SIXU
Utilities
SIXU
+०.८२%
८९४.१७
+७.२५
+०.८२%
—८८६.९२८८५.२३८९६.८३८८१.७४——
SIXV
Health care
SIXV
Health care
SIXV
+१.१६%
१,४८७.६२
+१७.१३
+१.१६%
—१,४७०.४९१,४७०.६८१,४९४.४२१,४६२.१६——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-१.०२%
२,३२५.८८
-२३.८९
-१.०२%
—२,३४९.७७२,३३२.१७२,३३२.१७२,३०७.४३——
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹ २४.४७
-०.४९%
(-०.१२) 1D
मे १९, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
₹ २४.१०
High
₹ २५.३५
Low
₹ २३.४०
Mkt. cap
१.३५ अरब
Avg. vol.
६७.६२ हजार
Volume
२४.९६ हजार
P/E ratio
१४.३०
52-wk high
₹ ६३.९०
52-wk low
₹ १५.२०
EPS
₹ १.७१
No. of employees
६००
News stories
From sources across the web
XTB.com
XTB.com
·
१५ मिनेट पहिले
Daily summary: Nasdaq tries to reverse the decline, EURUSD down 0.4%
MarketBeat
MarketBeat
·
३५ मिनेट पहिले
Intuit (NASDAQ:INTU) Shares Gap Up - What's Next?
TipRanks
TipRanks
·
५६ मिनेट पहिले
Comcast Stock (NASDAQ:CMCSA) Down as Priorities Pivot
Reuters
Reuters
·
१ घण्टा पहिले
Wall St slips as inflation worries push yields to new highs
About Balaxi Pharmaceuticals Ltd
CEO-
Employees६००
Founded१९४२
Headquarters-
Sector-
Websitebalaxipharma.in
Last report
२०२६ जनवरी २८
Fiscal Period
Q3 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
७२.५४ करोड / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
७६.२७ करोड
७०.७४ करोड
५६.१८ करोड
७२.५४ करोड
Cost of goods sold
३९.८० करोड
३९.५६ करोड
२९.०३ करोड
४१.७४ करोड
Cost of revenue
३९.८० करोड
३९.५६ करोड
२९.०३ करोड
४१.७४ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२३.९२ करोड
२७.०३ करोड
२५.९८ करोड
२७.७२ करोड
Operating expense
२४.३८ करोड
२७.५० करोड
२६.४६ करोड
२८.२८ करोड
Total operating expenses
६४.१७ करोड
६७.०६ करोड
५५.४९ करोड
७०.०१ करोड
Operating income
१२.०९ करोड
३.६९ करोड
६८.४१ लाख
२.५३ करोड
Other non operating income
४.३८ करोड
-१.७८ करोड
१.५८ करोड
९.५७ लाख
EBT including unusual items
९.६६ करोड
९०.३४ लाख
१.३८ करोड
१.६१ करोड
EBT excluding unusual items
९.६६ करोड
९०.३४ लाख
१.३८ करोड
१.६१ करोड
Income tax expense
१.०३ करोड
६१.३३ लाख
१.१७ करोड
१.३० करोड
Effective tax rate
१०.६१%
६७.८९%
८४.८२%
८१.०५%
Other operating expenses
-
-
-
-
Net income
८.६४ करोड
२९.०१ लाख
२०.९० लाख
३०.५० लाख
Net profit margin
११.३३%
०.४१%
०.३७%
०.४२%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-७३.५६ लाख
-१.०१ करोड
-८९.२२ लाख
-१.०२ करोड
Net interest expenses
-७३.५६ लाख
-१.०१ करोड
-८९.२२ लाख
-१.०२ करोड
Depreciation and amortization charges
४६.०९ लाख
४६.२५ लाख
४८.४५ लाख
५५.९५ लाख
EBITDA
१२.५२ करोड
४.११ करोड
१.१६ करोड
२.९६ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer